Preview

Kuban Scientific Medical Bulletin

Advanced search

Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma

Abstract

This study identified associations between mutation status of the BRAF gene and the clinico-morphological features of melanoma patients in the South of Russia of the age group over 55 years. It was carried out molecular genetic study of exon 15 of the BRAF gene sequencing method of Sanger and by RT-PCR in 35 patients in Southern Russia with morphologically confirmed diagnosis of skin melanoma. The study found that the presence of mutations in the gene BRAF was significantly associated with increasing tumor thickness according to Breslow. We also observed an increase in the frequency of ulceration of the tumor by 21% in patients with an activating V600 mutation. The frequency of detection of V600 mutations in the BRAF gene in tissues of melanoma was 40%.

About the Authors

O. I. Kit
Rostov research institute of oncology
Russian Federation


D. I. Vodolazhsky
Rostov research institute of oncology
Russian Federation


E. Yu. Zlatnik
Rostov research institute of oncology
Russian Federation


I. Yu. Efimova
Rostov research institute of oncology
Russian Federation


S. S. Kochuev
Rostov research institute of oncology
Russian Federation


Yu. V. Przhdetsky
Rostov research institute of oncology
Russian Federation


References

1. Кит О. И, Водолажский Д. И, и др. Сравнительная характеристика мутационного статуса гена BRAF в зависимости от клинико-морфологических особенностей меланомы кожи // Современные проблемы науки и образования. - 2005. - № 5.

2. Злокачественные новообразования в России. Обзор статистической информации за 1993-2013 гг. / Под общей редакцией чл. - корр. РАН, проф. А. Д. Каприна, проф. В. В. Старинского. М., 2015. - 511 с.

3. Balch C. M., Soong S.-J., Gershenwald J. E. et al. Prognostic factors analysis of 17600 melanoma patient: validation of the American Joint Committee on cancer melanoma staging system // J. clin. oncol. - 2001. - Vol. 19. - P. 3622-3634.

4. Bertolotto C. Melanoma: from melanocyte to genetic alterations and clinical options // Scientifica. - 2013. 2013:635203.

5. Davies H., Bignell G. R., Cox C. et al. Mutations of the BRAF gene in human cancer // Nature. - 2002. - № 417(6892). -P. 949-954.

6. Davies MA, Samuels Y. Analysis of the genome to personalize therapy for melanoma // Oncogene. - 2010 -№ 29 (41). - P 5545-5555.

7. Elder D. E., Van Belle P., Elenitsas R., et al. Neoplastic progression and prognosis in melanoma // Semin. cutan. med. surg. - 1996. - №15. - P. 336-348.

8. Hmonen S. Prognosis of primary melanoma // Scand. j. surg. - 2002. - Vol. 91. - P. 166-171.

9. Long G. V., Menzies A. M., Nargial A. M. et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma // J. clin. oncol. - 2011. - № 29. - Р. 1239-1246.

10. Menzies A., Haydu E., Visintin L et al. Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma // J. clin. cancer. res. - June. 2012. - № 18. - Р. 3242-3249.


Review

For citations:


Kit O.I., Vodolazhsky D.I., Zlatnik E.Yu., Efimova I.Yu., Kochuev S.S., Przhdetsky Yu.V. Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma. Kuban Scientific Medical Bulletin. 2016;(3):67-71. (In Russ.)

Views: 225


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1608-6228 (Print)
ISSN 2541-9544 (Online)